Jane Street Group, LLC Mirati Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $9.36 Million - $13.9 Million	222,917 Added 119.25%	409,843 $24.1 Million
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $1.19 Million - $1.95 Million	-42,957 Reduced 18.69%	186,926 $8.14 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $2.92 Million - $4 Million	80,755 Added 54.15%	229,883 $8.31 Million
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $1.5 Million - $2.23 Million	-41,092 Reduced 21.6%	149,128 $5.54 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $6.57 Million - $15.7 Million	159,188 Added 512.98%	190,220 $8.62 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $3.19 Million - $4.65 Million	-53,614 Reduced 63.34%	31,032 $2.17 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $3.19 Million - $4.65 Million	-53,614 Reduced 63.34%	31,032 $2.17 Million
Q2 2022 Aug 16, 2022	BUY	$39.16 - $88.71 $504,733 - $1.14 Million	12,889 Added 17.96%	84,646 $5.68 Million
Q1 2022 May 17, 2022	BUY	$75.82 - $150.97 $1.93 Million - $3.83 Million	25,399 Added 54.79%	71,757 $5.9 Million
Q4 2021 Feb 15, 2022	BUY	$132.01 - $190.29 $1.15 Million - $1.66 Million	8,706 Added 23.12%	46,358 $6.8 Million
Q3 2021 Nov 16, 2021	SELL	$132.13 - $177.45 $1.37 Million - $1.84 Million	-10,352 Reduced 21.56%	37,652 $6.66 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $4.87 Million - $6.08 Million	33,848 Added 239.11%	48,004 $7.75 Million
Q1 2021 May 18, 2021	SELL	$158.92 - $221.61 $1.81 Million - $2.52 Million	-11,361 Reduced 44.52%	14,156 $2.43 Million
Q4 2020 Feb 17, 2021	SELL	$162.05 - $240.27 $960,470 - $1.42 Million	-5,927 Reduced 18.85%	25,517 $5.61 Million
Q3 2020 Nov 17, 2020	BUY	$113.26 - $167.27 $2.97 Million - $4.39 Million	26,223 Added 502.26%	31,444 $5.22 Million
Q2 2020 Aug 17, 2020	BUY	$72.01 - $120.39 $129,401 - $216,340	1,797 Added 52.48%	5,221 $596,000
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $765,198 - $1.39 Million	-10,814 Reduced 75.95%	3,424 $441,000
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $1.11 Million - $1.56 Million	14,238 New	14,238 $1.11 Million
Q4 2018 Feb 15, 2019	SELL	$32.0 - $47.43 $226,144 - $335,187	-7,067 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $332,855 - $443,100	7,067 New	7,067 $333,000
Q4 2017 Feb 15, 2018	SELL	$12.65 - $19.0 $722,656 - $1.09 Million	-57,127 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $268,496 - $668,385	57,127	57,127 $668,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account